Volume 9 - Issue 1 (September - October 2023)
Detailed review on Bevacizumab and its target therapies
Article DOI: 10.53022/oarjbp.2023.9.1.0042DOI url: https://doi.org/10.53022/oarjbp.2023.9.1.0042
Carlos Henrique Marchiori
Article DOI: 10.53022/oarjbp.2023.9.1.0032DOI url: https://doi.org/10.53022/oarjbp.2023.9.1.0032
Sara Tabarsa, Arash Izadi, Ali Sarbazdalir, Newsha Eslami
Article DOI: 10.53022/oarjbp.2023.9.1.0033DOI url: https://doi.org/10.53022/oarjbp.2023.9.1.0033
Majedul Hoque, Arafath Jubayer, Md Aktaruzzaman, Md Nahid Hasan, Mohammad Sabbir Hossain, Taharat Akram, Shuvo Nath Saha
Article DOI: 10.53022/oarjbp.2023.9.1.0041DOI url: https://doi.org/10.53022/oarjbp.2023.9.1.0041
Detailed review on Bevacizumab and its target therapies
Ankit Kumar, S P Srinivas Nayak, Ronit Kumar Arvind
Article DOI: 10.53022/oarjbp.2023.9.1.0042DOI url: https://doi.org/10.53022/oarjbp.2023.9.1.0042
Zurisadai Raquel García Osorno, Augusto Ignacio Siegert Olivares, Paola Alejandra Cisneros Conklin, Ibeth Judith Reyes Montante, María Andrea Murillo Gallo
Article DOI: 10.53022/oarjbp.2023.9.1.0046DOI url: https://doi.org/10.53022/oarjbp.2023.9.1.0046
Nithya Raju, Shruthi Deivigarajan, Sindhuja Santhakumar, Sneha Balamurugan
Article DOI: 10.53022/oarjbp.2023.9.1.0037DOI url: https://doi.org/10.53022/oarjbp.2023.9.1.0037